Digital microscopic imaging company Optiscan (ASX: OIL) has gotten feedback from the US Food and Drug Administration (FDA) in relation to its Pre-Market Notification (510(k)) application for the InVivage product intended for oral tissue imaging. FDA’s regulatory clearance for the product requires that both the fluorescent contrast agent drug and the device used to visualise
Read More
Would you call selling your intellectual property to your own company a boss move? For Managing Director, Prof Camile Farah, heck yes. Endomicroscopic imaging tech company Optiscan Imaging (ASX: OIL) has entered into a binding Terms Sheet with Managing Director, Prof Camile Farah, to acquire intellectual property in the form of clinical and histopathological datasets.
Read More
With increasing health awareness across China, medtech company Optiscan (ASX: OIL) is set to increase the exposure of their in vivo microscopic imaging camera which can be thread through the human body for use in cancer detection and surgery. The increased exposure will come through a freshly inked distribution partnership with biotech company Sinsi Technology
Read More